TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05507684

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nature-based social prescribing group intervention
Description: Groups of 5-12 persons will formed from one assisted living facility. All of them will undergo an individual interview to assess their wishes for the nature-based activities.~Participants meet in a closed group for 9 times once a week for 10 weeks. All 2-4 hour sessions will include nature-based activities and mutual discussions about the experiences of nature and loneliness.~2 professionals will facilitate and observe the group more thoroughly, give feedback to each other, and make use of group dynamics. They write diaries on each session and receive feedback from their trainers. The groups are objective oriented (aiming to alleviate loneliness, to improve participants' self-efficacy), client oriented and aim with favorable group dynamics to mature, self-directing group in which the participants have made friends with each other and want meet with each other without the facilitators after the official group intervention is over.
Study: NCT05771623

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Iontophoresis drug delivery device
Description: Botulinum toxin type A (Botox Allergan ®, Irvine, CA, USA) is used. 100 U vacuum-dried powder in a single-use vial for reconstitution diluted in 2mL of sterile, preservative-free 0.9% saline to constitute a solution at a concentration of 4 U/0.1 mL) is being administered once a month for a total period of three months.~The dose will be adjusted to 2.5 U/cm2 of the scar. The dose shouldn't exceed 100 units per session.~This can be done through the Iontophoresis drug delivery device. Traditional PT: Stretching, deep friction massage and pressure therapy (2 times per week for 3 months).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional physical therapy
Description: Traditional PT: Stretching, deep friction massage and pressure therapy (2 times per week for 3 months).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional physical therapy
Description: Traditional PT: Stretching, deep friction massage and pressure therapy (2 times per week for 3 months).
Study: NCT05674708

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fat intake
Description: Four different sources of dietary fat

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fat intake
Description: Four different sources of dietary fat

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fat intake
Description: Four different sources of dietary fat

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fat intake
Description: Four different sources of dietary fat
Study: NCT06230523

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC.
Study: NCT06501937

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Influencer marketing
Description: Participants watched online survey-imbedded promotional videos featuring influencers

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Influencer marketing
Description: Participants watched online survey-imbedded promotional videos featuring influencers
Study: NCT05565404

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mobile health
Description: Scaling and root planing, interdental brushing demonstration and regular text messages in type 2 embrasure patients.
Study: NCT05565404

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scaling and root planing+Interdental aid
Description: Scaling and root planing, interdental brushing demonstration in type 2 embrasure patients.
Study: NCT05163535

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VM-1500A-LAI
Description: VM-1500A (parent drug of elsulfavirine) IM injection dosage form

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VM-1500A-LAI
Description: VM-1500A (parent drug of elsulfavirine) IM injection dosage form

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VM-1500A-LAI
Description: VM-1500A (parent drug of elsulfavirine) IM injection dosage form

Intervention type: OTHER
Group type: OTHER
Intervention: ELPIDA®
Description: Elsulfavirine capsules
Study: NCT05486702

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time Restricted Eating
Description: Time restricted eating (TRE) can be divided into early TRE (eTRE) and late TRE (lTRE), depending on the time of day of the eating window.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time Restricted Eating
Description: Time restricted eating (TRE) can be divided into early TRE (eTRE) and late TRE (lTRE), depending on the time of day of the eating window.
Study: NCT05351567

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EDUCATIONAL PROGRAM CREATED ACCORDING TO TRANSFORMATIONAL LEARNING THEORY
Description: EDUCATIONAL PROGRAM CREATED ACCORDING TO TRANSFORMATIONAL LEARNING THEORY FOR INFERTILITY FEMALES
Study: NCT05633862

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1015550
Description: BI 1015550

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1015550
Description: BI 1015550
Study: NCT05756478

Intervention type: OTHER
Group type: OTHER
Intervention: Medication review
Description: This is a feasibility study of implementing a pharmacist-led medication review using prescribing tools (e.g. STOPP/START, Beers Criteria)
Study: NCT04432636

Intervention type: OTHER
Group type: OTHER
Intervention: Data collection of environmental factors
Description: - Data collection of environmental factors (including maternal nutrition and social level, mode of delivery, birth weight, mode of infant feeding, antibiotic treatments) at the recruitment

Intervention type: OTHER
Group type: OTHER
Intervention: Collection of maternal feces
Description: - Collection of maternal feces: the first sample after delivery and once a week during the period of hospitalization of their infant (i.e. 5 to 8 samples per mother)

Intervention type: OTHER
Group type: OTHER
Intervention: Collection of infant feces
Description: - Collection of infant feces: the first sample after birth and once a week during the period of hospitalization of the baby (i.e. 5 to 8 samples per mother) and a sample collected at the corrected age of 1 year and 2 years (i.e. 8 to 10 samples per infant)

Intervention type: OTHER
Group type: OTHER
Intervention: food questionnaire
Description: - A food questionnaire completed by the mother the week after delivery,

Intervention type: OTHER
Group type: OTHER
Intervention: a food questionnaire on the infant alimentation and food behavior during the period of 2 and 10 months of age
Description: a food questionnaire on the infant alimentation and food behavior during the period of 2 and 10 months of age, completed by the parents and given to the pediatrician at the medical check-up at the corrected age of 1 year

Intervention type: OTHER
Group type: OTHER
Intervention: a food questionnaire on the infant alimentation and food behavior during the period of 12 and 24 months of age
Description: a food questionnaire on the infant alimentation and food behavior during the period of 12 and 24 months of age, completed by the parents and given to the pediatrician at the medical check-up at the corrected age of 2 years

Intervention type: OTHER
Group type: OTHER
Intervention: Sample of milk
Description: A sample of 15 mL of milk drunk by the preterm at the 7th postnatal day (if not possible between the 7th and the 10th postnatal days).

Intervention type: OTHER
Group type: OTHER
Intervention: The 'Ages and Stages Questionnaire' ASQ
Description: - The 'Ages and Stages Questionnaire' ASQ survey completed by the parents and given to the pediatrician at the corrected age of 2 years medical check-up
Study: NCT06230523

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC.
Study: NCT05054946

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic cystectomy
Description: All surgeries will be performed under general anesthesia by laparoscopically.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic cystectomy
Description: All surgeries will be performed under general anesthesia by laparoscopically.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic cystectomy
Description: All surgeries will be performed under general anesthesia by laparoscopically.
Study: NCT06374641

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mitochondrial Substrate Supplement
Description: Mitochondrial Substrate supplement, 2xdaily 65 mL drink
Study: NCT05314257

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Granisetron Hydrochloride
Description: IV granisetron 1mg

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% normal saline
Description: IV 5ml of 0.9% normal saline
Study: NCT06230523

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC.
Study: NCT06374641

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Mitochondrial Substrate Supplement
Description: Mitochondrial Substrate supplement, 2xdaily 65 mL drink
Study: NCT04584554

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BETTER Transitional Care Intervention
Description: Patient and family will receive pre- and post-discharge support and education from interventionist.
Study: NCT06374641

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo Supplement
Description: Placebo supplement, 2xdaily 65 mL drink

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Supplement
Description: Placebo supplement, 2xdaily 65 mL drink
Study: NCT06021743

Intervention type: DIAGNOSTIC_TEST
Intervention: Evaluation of the degree of steatosis
Description: The degree of steatosis will be estimated using the ultrasound and a method for grading steatosis will be measuring the degree of ultrasound attenuation by hepatic fat using a process based on simultaneous transient elastography (TE) which measures the degree of steatosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Screening for the components of metabolic syndrome
Description: Anthropometric measures including height, weight, waist circumference and hip circumference will be measured in all patients. Results of the routine laboratory tests as part of the standard diagnostic procedure will be collected: CRP, leukocyte count, ratio neutrophils and lymphocytes, hemoglobin, platelet count, urea, creatinine, bilirubin, AST, ALT, GGT, ALP, albumins, fasting glucose.

Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of serum semaphorin concentrations
Description: Semaphorin concentration will be measured in patient sera by ELISA.

Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of inflammatory cytokines
Description: A panel of pro- and anti-inflammatory markers will be determined by flow cytometer microsphere-based assay.
Study: NCT05664633

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sugammadex
Description: Sugammadex or G/N will be given at the end of the procedure once the surgeon communicates with the anesthesiologist. The surgeon will typically do this at the time of putting the closing sutures.
Study: NCT06056414

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Energy Resonance by Cutaneous Stimulation
Description: Energy Resonance by Cutaneous Stimulation session
Study: NCT05981794

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical heating pad
Description: A powered heating pad

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham heating pad
Description: A heating pad that is not powered on
Study: NCT05450653

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FETO with Goldballoon Detachable Balloon (GOLDBAL2) along with the delivery Microcatheter (BALTACCI-BDPE100)
Description: A Goldballoon Detachable Balloon (GOLDBAL2) will be inserted in the airway of the fetus with severe congenital diaphragmatic hernia (o/e LHR \<25% with liver up) during the FETO procedure between gestational age 27 weeks 0 days and 29 weeks and 6 days. The fetal tracheal balloon will be removed at between 34 weeks 0 days and 34 weeks 6 days gestation or earlier as indicated.
Study: NCT05581329

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Acupuncture is a method of inserting very thin needles into special points on the body which are called acupoints. To conduct this intervention, we will use disposable acupuncture needles the size of 0.30 x 13 mm to acupuncture the control acupoint (Yuji - LU10) in the first session and the research acupoint (Houxi - SI3) in the second session.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Acupuncture is a method of inserting very thin needles into special points on the body which are called acupoints. To conduct this intervention, we will use disposable acupuncture needles the size of 0.30 x 13 mm to acupuncture the control acupoint (Yuji - LU10) in the first session and the research acupoint (Houxi - SI3) in the second session.
Study: NCT06093984

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: duostim vs. two antagonist ovarian stimulations
Description: Human menopausal gonadotropin (HMG) 300 IU/day with flexible antagonist protocol is used for ovarian stimulation, except in luteal phase stimulation of the duostim group. In the duostim group, all of the embryos are frozen. Fresh transfers are performed in the control group, frozen embryo transfers are performed in both control and duostim groups.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: duostim vs. two antagonist ovarian stimulations
Description: Human menopausal gonadotropin (HMG) 300 IU/day with flexible antagonist protocol is used for ovarian stimulation, except in luteal phase stimulation of the duostim group. In the duostim group, all of the embryos are frozen. Fresh transfers are performed in the control group, frozen embryo transfers are performed in both control and duostim groups.
Study: NCT04866979

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental: Continuous TBS (cTBS)
Description: Application of cTBS. cTBS will be applied to the left dorsolateral prefrontal cortex (left DLPFC). The coil will be placed at the EEG 10-20 International System position of the F3 electrode. Stimulation parameters will be TBS delivery of 600 pulses divided into blocks of 3 pulses at 50 Hz, which are applied at 5 Hz (every 200 ms), with a stimulation intensity equal to 80% of the motor threshold value at rest.
Study: NCT06230523

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC.
Study: NCT06287229

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Blinatumomab
Description: Given by Infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inotuzumab Ozogamicin
Description: Given by IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyper-CVAD
Description: Given by IV Participants younger than 60 years of age, you will receive hyper-CVAD.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mini-hyper-CVD
Description: Given by IV Participants 60 years of age or older, you will receive mini-hyper-CVD
Study: NCT06144801

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CoolSense Group
Description: Patients in the CoolSense group received a CoolSense device that had been pre-chilled in the freezer for a minimum of one hour. The cover of the CoolSense device was removed, and the arteriovenous fistula, whose metal tip had been cleaned with batikon, was brought into contact with the area where the arteriovenous fistula cannulation would occur. This contact was maintained for 5 seconds, involving circular movements, and the fistula cannulation took place promptly.
Study: NCT04936880

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental : Virtual reality + analgesia-sedation
Description: Use of a virtual reality device + analgesia-sedation drugs according to SFMU/SFAR 2010 guidelines during reduction procedure

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control: Analgesia-sedation
Description: Use of analgesia-sedation drugs according to SFMU/SFAR 2010 guidelines during reduction procedure
Study: NCT04893850

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BRIDGE Therapy Program
Description: The BRIDGE Therapy Program is a novel manualized therapy that incorporates key parenting concepts and related Dialectical Behavior Therapy (DBT) modules. The primary aim of the program is to improve parent well-being and promote supportive parenting practices. There are two components of the program: 1) the DBT section, which will follow the DBT Skills Training Manual 2nd Edition and target parental mental health symptomology, and 2) the parent skill training materials, which have been designed to correspond to the four core DBT modules (i.e., Mindfulness, Emotion Regulation, Distress Tolerance, and Interpersonal Effectiveness) and to promote self-regulatory skill development and a positive parent-child relationship.
Study: NCT04866979

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental: Continuous TBS (cTBS)
Description: Application of cTBS. cTBS will be applied to the left dorsolateral prefrontal cortex (left DLPFC). The coil will be placed at the EEG 10-20 International System position of the F3 electrode. Stimulation parameters will be TBS delivery of 600 pulses divided into blocks of 3 pulses at 50 Hz, which are applied at 5 Hz (every 200 ms), with a stimulation intensity equal to 80% of the motor threshold value at rest.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent TBS (iTBS)
Description: Application of iTBS. iTBS will be applied to the left dorsolateral prefrontal cortex (left DLPFC). The coil will be placed at the EEG 10-20 International System position of the F3 electrode. Stimulation parameters will be TBS delivery of of 600 pulses divided into blocks of 3 pulses at 50 Hz, which are applied at 5 Hz (every 200 ms), alternating 2 seconds of stimulation with a pause of 8 seconds, with a stimulation intensity equal to 80% of the motor threshold value at rest.
Study: NCT04893850

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Services as Usual Clinical Referral list
Description: The community services as usual clinical referral list provides information on accessing psychological and family support services in Winnipeg. This resource is used to locate: crisis, distress, and support phone lines, counselling and peer-support resources, and free apps relating to mindfulness and meditation.
Study: NCT05689827

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ethyl methyl hydroxypyridine succinate + Meldonium
Description: Ethyl methyl hydroxypyridine succinate 100.0 mg/mL, meldonium dihydrate - 100.0 mg/mL (Solution for intravenous and intramuscular administration), then Ethyl methyl hydroxypyridine succinate - 250.0 mg, meldonium dihydrate based on dihydrate without adsorption moisture - 250.0 mg (oral capsules)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo was used in the same way
Study: NCT05045053

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xiidra 5% Ophthalmic Solution
Description: lifitegrast 0.5% ia applied twice daily after corneal collagen cross linking
Study: NCT04866979

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent TBS (iTBS)
Description: Application of iTBS. iTBS will be applied to the left dorsolateral prefrontal cortex (left DLPFC). The coil will be placed at the EEG 10-20 International System position of the F3 electrode. Stimulation parameters will be TBS delivery of of 600 pulses divided into blocks of 3 pulses at 50 Hz, which are applied at 5 Hz (every 200 ms), alternating 2 seconds of stimulation with a pause of 8 seconds, with a stimulation intensity equal to 80% of the motor threshold value at rest.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive training (CT).
Description: Cognitive training (memory rehabilitation via RehaCom computer software) of 25 min. The training will be focused on memory rehabilitation, implementing a face-name association paradigm. The software uses an individualized adaptive methodology based on the participant's performance.
Study: NCT06073314

Intervention type: DIAGNOSTIC_TEST
Intervention: Quantitative MRI
Description: Patients will be asked to remain in the scanner for an additional 10 minutes while we acquire additional quantitative MR images
Study: NCT04866979

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive training (CT).
Description: Cognitive training (memory rehabilitation via RehaCom computer software) of 25 min. The training will be focused on memory rehabilitation, implementing a face-name association paradigm. The software uses an individualized adaptive methodology based on the participant's performance.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive training (CT).
Description: Cognitive training (memory rehabilitation via RehaCom computer software) of 25 min. The training will be focused on memory rehabilitation, implementing a face-name association paradigm. The software uses an individualized adaptive methodology based on the participant's performance.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sham Stimulation (shamTBS)
Description: Sham rTMS (TBS) will be administered by applying a 30mm thick piece of wood or plastic to a real TMS coil during stimulation, and this additional element will be constructed in such a way that it appears to be an integral part of the apparatus such that the patient remains unaware that they are not receiving stimulation (Rossi et al., 2007 ).This 30mm distance is adequate to ensure that the magnetic pulse does not reach the cortex.
Study: NCT06414200

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: multidisciplinary structured tailored made nutritional advice
Description: The goal is a structured follow-up after discharge. Parents need to fill in questionnaires about eating behavior en feeding difficulties about their child. They also need to fill in a questionnaire about their stress. Together with their nutritional intake (3-days food diary) and growth a tailor-made nutritional plan is made. All the information I showed in a dashboard and discussed it with their dietitian. Who discusses this information in a multi-disciplinary team (pediatrician, psychologist and if needed a speech therapist).